BMAL2 and lung adenocarcinoma: In lung adenocarcinoma, ITGB1-DT can also serve as a diagnostic marker and can regulate the ARNTL2 and Wnt/β-catenin pathways to influence the immune microenvironment and the development of lung adenocarcinoma [17].